학술논문
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
Document Type
Article
Author
Sharma, M.; Bangdiwala, S.I.; Amarenco, P.; Molina, C.A.; Toyoda, K.; Bereczki, D.; Kasner, S.E.; Lutsep, H.L.; Tsivgoulis, G.; Ntaios, G.; Czlonkowska, A.; Shuaib, A.; Endres, M.; Yoon, B.-W.; Tanne, D.; Toni, D.; Yperzeele, L.; von Weitzel-Mudersbach, P.; Sampaio Silva, G.; Avezum, A.; Dawson, J.; Strbian, D.; Tatlisumak, T.; Eckstein, J.; Ameriso, S.F.; Weber, J.R.; Sandset, E.C.; Goar Pogosova, N.; Lavados, P.M.; Arauz, A.; Gailani, D.; Diener, H.-C.; Bernstein, R.A.; Cordonnier, C.; Kahl, A.; Abelian, G.; Donovan, M.; Pachai, C.; Li, D.; Hankey, G.J.
Source
In: The Lancet Neurology . (The Lancet Neurology, January 2024, 23(1):46-59)
Subject
Language
English
ISSN
14744465
14744422
14744422